(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 7.29% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Sight Sciences's revenue in 2025 is $78,109,000.On average, 2 Wall Street analysts forecast SGHT's revenue for 2025 to be $3,776,579,018, with the lowest SGHT revenue forecast at $3,748,401,380, and the highest SGHT revenue forecast at $3,804,756,656. On average, 3 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,299,235,426, with the lowest SGHT revenue forecast at $4,191,488,274, and the highest SGHT revenue forecast at $4,430,507,027.
In 2027, SGHT is forecast to generate $5,016,912,109 in revenue, with the lowest revenue forecast at $4,750,387,845 and the highest revenue forecast at $5,471,425,165.